{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:12:09Z","timestamp":1789506729143,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","award":["260050"],"award-info":[{"award-number":["260050"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"publisher","award":["26030153"],"award-info":[{"award-number":["26030153"]}],"id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128979","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:58:17Z","timestamp":1785369497000},"page":"128979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Polymorphisms in the Bordetella pertussis virulence factor SphB1 and altered antigen expression of clinical isolates before and after acellular pertussis vaccination in Finland"],"prefix":"10.1016","volume":"88","author":[{"given":"Vili","family":"Niinikoski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Myllyl\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex-Mikael","family":"Barkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2026.128979_bb0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3201\/eid2706.203850","article-title":"Pertactin-deficient Bordetella pertussis, vaccine-driven evolution, and Reemergence of pertussis","volume":"27","author":"Ma","year":"2021","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128979_bb0010","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1080\/21505594.2021.1980987","article-title":"Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host","volume":"12","author":"Belcher","year":"2021","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128979_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2009.10.007","article-title":"Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen","volume":"10","author":"Mooi","year":"2010","journal-title":"Infect. Genet. Evol."},{"issue":"8","key":"10.1016\/j.vaccine.2026.128979_bb0020","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1508.081511","article-title":"Bordetella pertussis strains with increased toxin production associated with pertussis resurgence","volume":"15","author":"Mooi","year":"2009","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128979_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01074-14","article-title":"Global population structure and evolution of Bordetella pertussis and their relationship with vaccination","volume":"5","author":"Bart","year":"2014","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128979_bb0030","article-title":"Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vaccine.2026.128979_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103247","article-title":"Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: a collaborative study in Finland, the Netherlands, and the United Kingdom","volume":"65","author":"Versteegen","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.128979_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127279","article-title":"Alterations in the expression of Bordetella pertussis antigens in relation to the use of acellular pertussis vaccine in Finland","volume":"58","author":"Niinikoski","year":"2025","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128979_bb0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.49.2400765","article-title":"Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024","volume":"29","author":"Miettinen","year":"2024","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128979_bb0050","doi-asserted-by":"crossref","first-page":"683.e1","DOI":"10.1016\/j.cmi.2024.01.021","article-title":"Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation","volume":"30","author":"Niinikoski","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"10.1016\/j.vaccine.2026.128979_bb0055","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832","article-title":"Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015","volume":"24","author":"Barkoff","year":"2019","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128979_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01998-17","article-title":"Surveillance of circulating Bordetella pertussis strains in Europe during 1998 to 2015","volume":"56","author":"Barkoff","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"43","key":"10.1016\/j.vaccine.2026.128979_bb0065","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","article-title":"First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin","volume":"27","author":"Bouchez","year":"2009","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2026.128979_bb0070","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1093\/emboj\/20.18.5040","article-title":"Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway","volume":"20","author":"Coutte","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.vaccine.2026.128979_bb0075","series-title":"Advances in experimental medicine and biology","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/5584_2019_402","article-title":"Molecular epidemiology of Bordetella pertussis","volume":"1183","author":"Barkoff","year":"2019"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128979_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00632-24","article-title":"Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells","volume":"15","author":"Nash","year":"2024","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128979_bb0085","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/vaccines3030751","article-title":"New data on vaccine antigen deficient Bordetella pertussis isolates","volume":"3","author":"Bouchez","year":"2015","journal-title":"Vaccines (Basel)"},{"issue":"44","key":"10.1016\/j.vaccine.2026.128979_bb0090","doi-asserted-by":"crossref","first-page":"26370","DOI":"10.1074\/jbc.270.44.26370","article-title":"Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes","volume":"270","author":"Rose","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128979_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2180-8-162","article-title":"Bordetella pertussis isolates in Finland: serotype and Fimbrial expression","volume":"8","author":"Heikkinen","year":"2008","journal-title":"BMC Microbiol."},{"issue":"6","key":"10.1016\/j.vaccine.2026.128979_bb0100","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1128\/IAI.67.6.3133-3134.1999","article-title":"Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland","volume":"67","author":"Mooi","year":"1999","journal-title":"Infect. Immun."},{"issue":"642","key":"10.1016\/j.vaccine.2026.128979_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3253","article-title":"Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis","volume":"14","author":"Lefrancq","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.vaccine.2026.128979_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2026.106718","article-title":"Evolutionary dynamics and global spread of macrolide-resistant Bordetella pertussis during the post-pandemic pertussis resurgence","volume":"92","author":"Zhang","year":"2026","journal-title":"J. Inf."},{"issue":"4","key":"10.1016\/j.vaccine.2026.128979_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0950268813000071","article-title":"Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin","volume":"142","author":"Mooi","year":"2014","journal-title":"Epidemiol. Infect."},{"issue":"7","key":"10.1016\/j.vaccine.2026.128979_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105152","article-title":"Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype","volume":"25","author":"Matczak","year":"2023","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128979_bb0125","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/s41598-023-34672-0","article-title":"Fim3-dependent autoagglutination of Bordetella pertussis","volume":"13","author":"Otsuka","year":"2023","journal-title":"Sci. Rep."},{"issue":"6787","key":"10.1016\/j.vaccine.2026.128979_bb0130","first-page":"825","article-title":"Bacteria deliver a microtubule-binding protein into mammalian cells to promote colonization","volume":"391","author":"Costello","year":"2026","journal-title":"Science (1979)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:47:43Z","timestamp":1789505263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"alternative-id":["S0264410X26007887"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128979","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms in the Bordetella pertussis virulence factor SphB1 and altered antigen expression of clinical isolates before and after acellular pertussis vaccination in Finland","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128979"}}